Inhibition of Flt3-activating mutations
✍
Emilio Siendones; Nuria Barbarroja; Luis Arístides Torres; Paula Buendía; Franci
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 344 KB
👁 1 views
## Abstract The Flt3 receptor tyrosine kinase is a critical mediator in the pathogenesis of acute myeloid leukaemia (AML). Flt3‐activating mutations have been associated with poor prognosis and decreased overall survival of AML patients, thus Flt3 constitutes an ideal target for drug treatment of s